Drug profile · INN
risperidone
OKEDI
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
risperidone (OKEDI) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11712475
Sustained delivery formulations of risperidone compound
granted -
US 11013809
Sustained delivery formulations of risperidone compound
granted -
US 10376590
Sustained delivery formulations of risperidone compound
granted -
US 10010612
Sustained delivery formulations of risperidone compounds
granted -
US 9186413
Sustained delivery formulations of risperidone compounds
granted -
US 9180197
Sustained delivery formulations of risperidone compounds
granted -
US 9107832
Risperidone microparticles formed by sublimation
granted -
US 9050343
Combination of pimavanserin and risperidone for the treatment of psychosis
granted
Frequently asked questions
What is risperidone?
risperidone (OKEDI) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for risperidone?
OKEDI is a marketed brand name for risperidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of risperidone?
risperidone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.